A Study of V132 in Healthy Older Participants (V132-001)
NCT07712575
This study is recruiting at 10 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this study is to learn about the safety and immune response to the V132 vaccine in healthy older adults.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Healthy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 50 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Merck Sharp & Dohme LLC
- Last updated on ClinicalTrials.gov
- October 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Anaheim Clinical Trials ( Site 0006) · Anaheim, CA
Florida · 3
- Velocity Clinical Research, Hallandale Beach ( Site 0003) · Hallandale, FL
- Research Centers of America ( Hollywood ) ( Site 0009) · Hollywood, FL
- QPS-MRA, LLC-Early Phase ( Site 0001) · South Miami, FL
Missouri · 1
- Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0002) · Springfield, MO
Nebraska · 2
- Velocity Clinical Research Lincoln ( Site 0007) · Lincoln, NE
- Velocity Clinical Research, Omaha ( Site 0008) · Omaha, NE
Ohio · 1
- Remington-Davis, Inc. ( Site 0005) · Columbus, OH
Rhode Island · 1
- Velocity Clinical Research, Providence ( Site 0010) · East Greenwich, RI
Texas · 1
- University of Texas Medical Branch ( Site 0004) · League City, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.